MedTrace Logo

Stimulation to Improve Memory

NCT03875326 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 269

Last updated 2025-10-17

No results posted yet for this study

Summary

This study will test the effects of different doses of a form of non-invasive brain stimulation for the treatment of individuals with mild cognitive impairment (MCI) and dementia of the Alzheimer's Type (DAT).

Conditions

Interventions

DEVICE

1 mA HD-tDCS

Participants will receive HD-tDCS at 1 mA for 30 minutes, for between 5-30 sessions.

DEVICE

2 mA HD-tDCS

Participants will receive HD-tDCS at 2 mA for 30 minutes, for between 5-30 sessions.

DEVICE

3 mA HD-tDCS

Participants will receive HD-tDCS at 3 mA for 30 minutes, for between 5-30 sessions.

DEVICE

Sham

Participants will receive sham (placebo) HD-tDCS for 30 minutes, for between 5-30 sessions.

Sponsors & Collaborators

Principal Investigators

  • Benjamin Hampstead, PhD · Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2024-12-06
Completion
2024-12-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03875326 on ClinicalTrials.gov